0001209191-24-002512.txt : 20240131 0001209191-24-002512.hdr.sgml : 20240131 20240131203953 ACCESSION NUMBER: 0001209191-24-002512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240131 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lian Brian CENTRAL INDEX KEY: 0001614578 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 24584670 MAIL ADDRESS: STREET 1: C/O SEELOS THERAPEUTICS, INC. STREET 2: 300 PARK AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-01-31 0 0001607678 Viking Therapeutics, Inc. VKTX 0001614578 Lian Brian C/O VIKING THERAPEUTICS, INC. 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 1 1 0 0 President & CEO 1 Common Stock, par value $0.00001 per share 2024-01-31 4 M 0 85000 1.23 A 2349882 D Common Stock, par value $0.00001 per share 2024-01-31 4 S 0 40000 24.45 D 2309882 D Common Stock, par value $0.00001 per share 2024-01-31 4 S 0 45000 24.95 D 2264882 D Stock Option (right to buy) 1.23 2024-01-31 4 M 0 85000 0.00 D 2018-01-05 2027-01-05 Common Stock 85000 14148 D The transactions reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the Reporting Person on September 29, 2023. 25% of the shares subject to the option vested on each one year anniversary of the grant date. /s/ Michael Morneau, as Attorney-in-Fact 2024-01-31